News GSK wins the vote contest in FDA’s RSV vaccine panels Advisory committee votes unanimously that RSVPreF3 shot is effective, and 10-2 on safety.
News Pfizer’s RSV shot clears FDA adcomm; now it’s GSK’s turn There was debate about cases of Guillain Barré and the population of the phase 3 RENOIR trial.
News Santhera shores up funding ahead of vamorolone verdict The FDA is due to deliver a verdict on vamorolone in Duchenne muscular dystrophy in October.
R&D Healthcare brands are caught in a data privacy trap The digital advertising industry must adapt or accept the consequences of compliance failures.
R&D Optimisation of signal management in pharmacovigilance Signal management is a fundamental aspect of pharmacovigilance, required by regulatory agencies
R&D How connected compliance technology will improve pharmaceuti... Regulatory and compliance issues have weighed down the pharmaceutical environment for decades.
News Sobi plans filings for gout drug after phase 3 readout SEL-212 will compete with Horizon's fast-growing Krystexxa if approved by the FDA.
R&D Sponsored An inside guide to unlocking clinical research in the UK An inside guide to unlocking clinical research in the UK
